Maitake Products, Inc. (MPI) is a pioneer and leader of the highest quality dietary supplements derived from medicinal mushrooms. MPI was first created to introduce wonderful health benefits of Maitake mushroom (Grifola frondosa) to American people back in 1991. Since then MPI has been devoted to protect and promote health and well-being of the people by studying, developing, manufacturing, and marketing the highest quality nutritional supplements derived from medicinal mushrooms. Now MPI's products are available in more than 30 countries worldwide.
Maitake Products, Inc.(MPI) is a dietary supplement company whose major products are derived from medicinal mushrooms. We take pride that we are the pioneer who has introduced the wonderful health benefits of Maitake (Grifola frondosa), an Asian edible and medicinal mushroom, to the US for the first time. We are also proud to have devoted ourselves to the development and production of quality products supported by scientific studies, thereby defining and leading the "medicinal mushroom" market in the US since 1991.
Our goal is to contribute to the improvement in the health of our customers by providing reliable products with reliable information. There are many dietary supplement companies who have great skills in marketing and advertisement, but don't pay much attention to the quality or scientific basis of their products. We are different from them. We want to be the supplier of the very best products and the most useful information for you. We are not a big company, but we make every effort to conduct our own studies on our own products. Research is vital to us, as we want to be 100% confident when we recommend our products to our customers.
We hope we can serve as a bridge. We have brought the essence of the wisdom of ancient Asian people to the US, and made it into a form of modern dietary supplements supported by scientific studies for the health of the American people. In turn, we have introduced excellent Western dietary supplements to the Japanese market to contribute to the healthy and joyful life of the Japanese people. We hope we can expand our international activities functioning as a mediator and translator between the East and West, tradition and science, and general public and medical professionals.
To summarize, we are committed to making our best efforts to accomplish the following:
Maitake Products, Inc.(MPI) understands the critical significance of scientific studies to ensure the credibility and best use of its products. MPI puts a high priority on these studies, and has supported many of them conducted by various research institutes in Japan as well as in the US. These institutes include Kobe Pharmaceutical University, Shizuoka University and Showa University in Japan, and National Cancer Institutes, Georgetown University, Cancer Treatment Centers of America and New York Medical College in the US.
Also, it should be noted that MPI has received the IND (Investigational New Drug) approval from the FDA for its Grifron®-Pro Maitake D-Fraction® (Tincture) for Phase II clinical studies on advanced breast and prostate cancer patients. It is very exceptional for a dietary supplement company to be successful in obtaining an IND approval for a dietary supplement product, since this has traditionally been regarded as a process by which giant pharmaceutical companies develop new drugs. However, it serves as a sign of the excellent quality of this product and the high standards of MPI.
Researchers who are interested in studying MPI's products are encouraged to contact us for details.